Lansford Todd, Campbell Peter, Hassanzadeh Hamid, Weinstein Marc, Wind Joshua, Beaumont Andrew, Vokshoor Amir, Radcliff Kristen, Aleem Ilyas, Coric Domagoj
South Carolina Sports Medicine, Charleston, SC, USA.
Spine Institute of Louisiana, Shreveport, Louisiana, USA.
Orthop Rev (Pavia). 2024 Oct 3;16:122534. doi: 10.52965/001c.122534. eCollection 2024.
Certain demographics and/or risk factors contribute to complications following cervical spinal surgery including pseudarthrosis, prolonged pain, and reduced quality of life (QoL). Pulsed electromagnetic field (PEMF) stimulation is a non-invasive therapy that may enhance fusion success in at-risk patients.
To evaluate the safety and efficacy of post-operative adjunctive PEMF therapy following cervical spinal surgery in subjects at risk for pseudarthrosis.
This prospective, multicenter study investigated PEMF as an adjunctive therapy to cervical spinal fusion procedures in subjects at risk for pseudarthrosis based on having at least one of the following: prior failed fusion, multi-level fusion, nicotine use, osteoporosis, or diabetes. Radiographic fusion status and patient-reported outcomes (SF-36, EQ5D, NDI, and VAS-arm pain and VAS-neck pain) were assessed.
A total of 160 subjects were assessed for fusion 12-months postoperative, and 144 subjects were successfully fused (90.0%). Fusion success for subjects with 1, 2+, or 3+ risk factors was 91.7%, 89.0%%, and 90.9%, respectively. Significant improvements in NDI, VAS-arm and VAS-neck were observed compared to baseline scores (p < 0.001) along with improvements in SF-36 and EQ5D (p < 0.001).
Adjunctive treatment with PEMF provides a high rate of successful fusion and significant improvements in pain, function, and quality of life despite having risk factors for pseudarthrosis.
某些人口统计学特征和/或风险因素会导致颈椎手术后出现并发症,包括假关节形成、长期疼痛和生活质量(QoL)下降。脉冲电磁场(PEMF)刺激是一种非侵入性治疗方法,可能会提高高危患者的融合成功率。
评估颈椎手术后辅助性PEMF治疗对有假关节形成风险的受试者的安全性和有效性。
这项前瞻性、多中心研究调查了PEMF作为颈椎融合手术辅助治疗方法对有假关节形成风险的受试者的疗效,这些受试者至少具备以下一项特征:既往融合失败、多节段融合、吸烟、骨质疏松或糖尿病。评估影像学融合状态和患者报告的结局(SF-36、EQ5D、NDI以及手臂VAS疼痛和颈部VAS疼痛)。
共有160名受试者在术后12个月接受融合评估,144名受试者成功融合(90.0%)。有1个、2个及以上或3个及以上风险因素的受试者的融合成功率分别为91.7%、89.0%和90.9%。与基线评分相比,NDI、手臂VAS和颈部VAS有显著改善(p<0.001),SF-36和EQ5D也有改善(p<0.001)。
尽管存在假关节形成的风险因素,但PEMF辅助治疗仍能提供较高的融合成功率,并在疼痛、功能和生活质量方面有显著改善。